Read the QTY in full tutes...
Uranium Sales
The Company made no uranium sales during Q3 CY2023.
At 30 September 2023, the Company’s committed sales contracts amounted to 4.8million pounds U3O8
and 0.15 million pounds U3O8 for sales optional at the election of the customers. Delivery is between now
and the end of 2034. Sales under existing contracts with major utilities in both United States and Europe
comprise up to 34% of the Ross & Kendrick LoM planned production.
Due to the re-start of production at Lance shifting to December 2024, Company produced uranium will
not be available to meet nearer term delivery commitments. The Company has held discussions with its
customer base to address recent developments regarding production plans and implications for
scheduled deliveries in CY2023 and CY2024. Agreement with existing customers is well advanced, to
align delivery schedules with forecast production in support of the Lance restart.
Uranium Inventory
The Company has a balance of 210,000 pounds U3O8 inventory. The inventory is expected to be
monetised by satisfying nearer term offtake requirements alongside finalisation of agreement with
customers to re-align the delivery schedule with forecast production.
- Forums
- ASX - By Stock
- PEN
- Ann: Quarterly Cashflow Report
Ann: Quarterly Cashflow Report, page-7
Featured News
Add PEN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
-0.021(25.3%) |
Mkt cap ! $197.6M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 6.1¢ | $8.401M | 126.7M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 2735758 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 494493 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 2490861 | 0.061 |
26 | 3014378 | 0.060 |
11 | 839551 | 0.059 |
6 | 2263059 | 0.058 |
3 | 90800 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 113635 | 3 |
0.064 | 570000 | 5 |
0.065 | 1252967 | 7 |
0.066 | 220000 | 2 |
0.067 | 323253 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PEN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online